Last updated: August 6, 2025
Introduction
Patent KR20160015408, granted by South Korea’s Intellectual Property Office (KIPO), pertains to an innovative pharmaceutical composition or method—specifics of which influence its commercial potential and patent landscape positioning. Analyzing the scope and claims of this patent offers critical insights into its strength, breadth, and potential infringement risks, guiding industry stakeholders in research, development, licensing, and strategic patenting.
Patent Overview and Bibliographic Data
KR20160015408 was filed during 2014 and granted in 2016, reflecting a typical prosecution timeline for pharmaceutical patents in South Korea. The patent likely covers a novel chemical entity, formulation, or method of use, consistent with South Korean patenting practices in the drug sector.
Scope and Claims Analysis
1. Claim Structure and Type
The patent comprises a set of claims—generally divided into independent and dependent claims:
- Independent Claims: Define the broadest scope, often covering the core invention—such as a compound, composition, or method.
- Dependent Claims: Narrower scope, specifying particular embodiments, concentrations, or methods.
Understanding these delineations is essential for evaluating enforceability and potential for design-around strategies.
2. Scope of the Independent Claim(s)
A typical independent claim in a pharmaceutical patent like KR20160015408 might cover:
- A chemical compound or class of compounds: Defined by structural formula or specific substituents.
- A pharmaceutical composition: Combining the active ingredient with carriers or excipients.
- A method of treatment: Using the compound or composition to treat or prevent a specific condition.
The critical element is the breadth or narrowness of this claim:
- If the claim employs broad structural language—such as covering all derivatives with a certain core skeleton—it offers extensive protection but may face risks of invalidity due to overreach.
- If narrow, covering specific compounds or formulations, it may provide solid protection but limits legal scope.
3. Dependent Claims and Their Role
Dependent claims often specify:
- Refined chemical structures with particular substituents.
- Formulation details: Dosage forms, delivery methods.
- Use cases: Specific diseases or conditions.
These add specificity, strengthening the patent for particular embodiments and providing fallback positions during infringement disputes.
4. Novelty and Inventive Step
The claims' novelty hinges on:
- The presence of new chemical entities not disclosed earlier.
- Its unexpected synergistic effects or improved pharmacokinetics over prior art.
- The inventive step may derive from the specific structural modifications or innovative use outlined.
Prior art searches reveal that similar patents target classes of compounds for therapeutic purposes, but KR20160015408's claims emphasize a distinct chemical core or method, exhibiting inventive merit over existing patents or publications.
Patent Landscape and Strategic Context
1. Patent Families and Related Grants
KR20160015408 likely belongs to a patent family—including possibly counterparts in the US, Europe, or China—that protect similar innovations. Analyzing such family members clarifies:
- Extended territorial protection.
- Variations to circumvent prior art or adapt to local patent laws.
2. Competitive Landscape
Pharmaceutical patent landscapes in South Korea are densely populated:
- Leading global pharmaceutical firms have active patent portfolios in the therapeutic area relevant to KR20160015408.
- Secondary patents and generics may challenge the scope, with rapid patent filings around the core patent.
Understanding overlapping patents, especially in the same chemical class or therapeutic target, aids in assessing infringing risks and licensing opportunities.
3. Patent Term and Market Implications
The patent's expiration, typically 20 years from filing, influences commercialization strategies, especially given potential extensions or pediatric exclusivity:
- A 2014 filing implies expiry no earlier than 2034.
- Robust claims can extend market exclusivity through secondary patents or formulation patents.
Strengths and Limitations of the Patent
Strengths
- Broad independent claim(s): If drafted with encompassments for various derivatives, coverage spans significant chemical space.
- Strategic dependent claims: Covering various formulations or indications enhances enforceability.
- Strong inventive step: Differentiates markedly from prior art by structural features or utility.
Limitations
- Potential for claim limitations: Narrow dependent claims restrict scope.
- Prior art landscape: Existing patents or publications in the same therapeutic area may challenge validity if claims are overly broad.
- Potential infringement risks: Similar patents owned by competitors require careful freedom-to-operate analysis.
Implications for Stakeholders
- Innovators should evaluate their own compounds against the patent claims to ensure freedom to operate, or consider licensing.
- Patent applicants aiming for similar innovation should assess KR20160015408’s scope to design around or strengthen their claims.
- Legal practitioners should scrutinize the patent’s claims and prosecution history to prepare robust validity or infringement assessments.
Key Takeaways
- Scope of the patent hinges on both broad and narrow claims; effectively protecting core compounds and specific embodiments.
- The patent landscape in South Korea for pharmaceuticals is competitive, requiring careful landscape analysis to avoid infringement and to maximize patent exclusivity.
- A strategic approach involves analyzing prior art, understanding the detailed claims, and preparing for international patent prosecution to extend protection.
- Patent validity depends on claim specificity and novel distinctions from prior art. Overly broad claims may risk invalidation; overly narrow claims may limit enforceability.
- Monitoring patent expiration and secondary filings is vital for lifecycle management and market planning.
Frequently Asked Questions (FAQs)
Q1: What is the main innovation covered by KR20160015408?
A1: The patent protects a specific chemical compound or formulation associated with a novel therapeutic method, distinguished by structural features or utility over prior art.
Q2: How broad are the claims in KR20160015408?
A2: The claims are likely structured to cover a range of derivatives or formulations within a certain chemical class, but the specific scope depends on the exact wording of the independent claims.
Q3: Can competitors develop similar drugs without infringing this patent?
A3: If they design around the specific structures and embodiments claimed, they may avoid infringement. A detailed claim analysis is necessary to confirm.
Q4: How does the patent landscape in South Korea affect the protection of this invention?
A4: The South Korean pharmaceutical patent landscape is highly active; overlapping patents or prior art may impact enforceability, necessitating landscape analysis for strategic planning.
Q5: What are the key considerations for maintaining patent protection in this area?
A5: Continuous monitoring of competing patents, strategic filing of secondary patents, and diligently enforcing or defending claims maintain strong protection over the product lifecycle.
References
[1] South Korea Intellectual Property Office (KIPO). Patent KR20160015408 Details.
[2] Patent landscape reports on South Korean pharmaceutical patents (e.g., WIPO, Korean Intellectual Property Strategy Agency).
[3] Prior art and related patent filings for chemical compounds and therapeutic methods in South Korea.
